Showing 1 - 16 results of 16 for search 'Thomas Klingebiel', query time: 2.65s Refine Results
  1. 1
    Treatment and outcome of the patients with rhabdomyosarcoma of the biliary tree: Experience of the Cooperative Weichteilsarkom Studiengruppe (CWS)

    Treatment and outcome of the patients with rhabdomyosarcoma of the biliary tree: Experience of the Cooperative Weichteilsarkom Studiengruppe (CWS) by Cristian Urla, Steven W. Warmann, Monika Sparber-Sauer, Andreas Schuck, Ivo Leuschner, Thomas Klingebiel, Gunnar Blumenstock, Guido Seitz, Ewa Koscielniak, Jörg Fuchs

    Published 2019-10-01
    Get full text
    Article
  2. 2
    Genetic Alterations and Resectability Predict Outcome in Patients with Neuroblastoma Assigned to High-Risk Solely by <i>MYCN</i> Amplification

    Genetic Alterations and Resectability Predict Outcome in Patients with Neuroblastoma Assigned to High-Risk Solely by <i>MYCN</i> Amplification by Frank Berthold, Angela Ernst, Sandra Ackermann, Christoph Bartenhagen, Holger Christiansen, Barbara Hero, Carolina Rosswog, Dietrich von Schweinitz, Thomas Klingebiel, Irene Schmid, Thorsten Simon, Matthias Fischer

    Published 2021-08-01
    Get full text
    Article
  3. 3
    The Phenotype and Functional Activity of Mesenchymal Stromal Cells in Pediatric Patients with Non-Malignant Hematological Diseases

    The Phenotype and Functional Activity of Mesenchymal Stromal Cells in Pediatric Patients with Non-Malignant Hematological Diseases by Zyrafete Kuҫi, Christiane Jordan, Sibylle Wehner, Jan Sörensen, Andrea Jarisch, Emilia Salzmann-Manrique, Lisa-Marie Pfeffermann, Thomas Klingebiel, Peter Bader, Selim Kuҫi

    Published 2020-02-01
    Get full text
    Article
  4. 4
    Overcrowding in a neonatal intermediate care unit: impact on the incidence of multidrug-resistant gram-negative organisms

    Overcrowding in a neonatal intermediate care unit: impact on the incidence of multidrug-resistant gram-negative organisms by Doris Fischer, Rolf L. Schlößer, Volkhard A. J. Kempf, Thomas A. Wichelhaus, Thomas Klingebiel, Sabine Philippi, Linda Falgenhauer, Can Imirzalioglu, Udo Dahl, Christian Brandt, Claudia Reinheimer

    Published 2019-04-01
    Get full text
    Article
  5. 5
    Improving Clinical Manufacturing of IL-15 Activated Cytokine-Induced Killer (CIK) Cells

    Improving Clinical Manufacturing of IL-15 Activated Cytokine-Induced Killer (CIK) Cells by Melanie Bremm, Lisa-Marie Pfeffermann, Claudia Cappel, Verena Katzki, Stephanie Erben, Sibille Betz, Andrea Quaiser, Michael Merker, Halvard Bonig, Michael Schmidt, Thomas Klingebiel, Peter Bader, Sabine Huenecke, Eva Rettinger

    Published 2019-05-01
    Get full text
    Article
  6. 6
    Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34+-Selected to CD3/CD19-Depleted Grafts in a Retrospective Multicenter Study

    Joint Modeling of Immune Reconstitution Post Haploidentical Stem Cell Transplantation in Pediatric Patients With Acute Leukemia Comparing CD34+-Selected to CD3/CD19-Depleted Grafts... by Emilia Salzmann-Manrique, Emilia Salzmann-Manrique, Melanie Bremm, Sabine Huenecke, Milena Stech, Andreas Orth, Matthias Eyrich, Ansgar Schulz, Ruth Esser, Thomas Klingebiel, Peter Bader, Eva Herrmann, Ulrike Koehl, Ulrike Koehl, Ulrike Koehl

    Published 2018-08-01
    Get full text
    Article
  7. 7
    Long-Term Clinical Outcome and Prognostic Factors of Children and Adolescents with Localized Rhabdomyosarcoma Treated on the CWS-2002P Protocol

    Long-Term Clinical Outcome and Prognostic Factors of Children and Adolescents with Localized Rhabdomyosarcoma Treated on the CWS-2002P Protocol by Ewa Koscielniak, Bernd Blank, Christian Vokuhl, Bernarda Kazanowska, Ruth Ladenstein, Felix Niggli, Gustaf Ljungman, Rupert Handgretinger, Guido Seitz, Jörg Fuchs, Birgit Fröhlich, Monika Scheer, Rüdiger Wessalowski, Irene Schmid, Monika Sparber-Sauer, Thomas Klingebiel

    Published 2022-02-01
    Get full text
    Article
  8. 8
    IL-2 stimulated but not unstimulated NK cells induce selective disappearance of peripheral blood cells: concomitant results to a phase I/II study.

    IL-2 stimulated but not unstimulated NK cells induce selective disappearance of peripheral blood cells: concomitant results to a phase I/II study. by Claudia Brehm, Sabine Huenecke, Andrea Quaiser, Ruth Esser, Melanie Bremm, Stephan Kloess, Jan Soerensen, Hermann Kreyenberg, Christian Seidl, Petra S A Becker, Heiko Mühl, Thomas Klingebiel, Peter Bader, Jakob R Passweg, Dirk Schwabe, Ulrike Koehl

    Published 2011-01-01
    Get full text
    Article
  9. 9
    Impact of HACA on Immunomodulation and Treatment Toxicity Following ch14.18/CHO Long-Term Infusion with Interleukin-2: Results from a SIOPEN Phase 2 Trial

    Impact of HACA on Immunomodulation and Treatment Toxicity Following ch14.18/CHO Long-Term Infusion with Interleukin-2: Results from a SIOPEN Phase 2 Trial by Nikolai Siebert, Sascha Troschke-Meurer, Madlen Marx, Maxi Zumpe, Karoline Ehlert, Juliet Gray, Alberto Garaventa, Carla Manzitti, Shifra Ash, Thomas Klingebiel, James Beck, Victoria Castel, Dominique Valteau-Couanet, Hans Loibner, Ruth Ladenstein, Holger N. Lode

    Published 2018-10-01
    Get full text
    Article
  10. 10
    Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation.

    Sequential anti-cytomegalovirus response monitoring may allow prediction of cytomegalovirus reactivation after allogeneic stem cell transplantation. by Sylvia Borchers, Melanie Bremm, Thomas Lehrnbecher, Elke Dammann, Brigitte Pabst, Benno Wölk, Ruth Esser, Meral Yildiz, Matthias Eder, Michael Stadler, Peter Bader, Hans Martin, Andrea Jarisch, Gisbert Schneider, Thomas Klingebiel, Arnold Ganser, Eva M Weissinger, Ulrike Koehl

    Published 2012-01-01
    Get full text
    Article
  11. 11
    Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials

    Pediatric Patients with Stage IV Rhabdomyosarcoma Significantly Benefit from Long-Term Maintenance Therapy: Results of the CWS-IV 2002 and the CWS DOK IV 2004-Trials by Lars Tramsen, Konrad Bochennek, Monika Sparber-Sauer, Emilia Salzmann-Manrique, Monika Scheer, Tobias Dantonello, Arndt Borkhardt, Uta Dirksen, Anne Thorwarth, Jeanette Greiner, Martin Ebinger, Jadwiga Weclawek-Tompol, Ruth Ladenstein, Gustaf Ljungman, Erika Hallmen, Thomas Lehrnbecher, Ewa Koscielniak, Thomas Klingebiel

    Published 2023-03-01
    Get full text
    Article
  12. 12
    Age-Dependent Presentation and Clinical Course of 1465 Patients Aged 0 to Less than 18 Years with Ovarian or Testicular Germ Cell Tumors; Data of the MAKEI 96 Protocol Revisited in the Light of Prenatal Germ Cell Biology

    Age-Dependent Presentation and Clinical Course of 1465 Patients Aged 0 to Less than 18 Years with Ovarian or Testicular Germ Cell Tumors; Data of the MAKEI 96 Protocol Revisited in... by Gabriele Calaminus, Dominik T. Schneider, Dietrich von Schweinitz, Heribert Jürgens, Nacera Infed, Stefan Schönberger, Thomas A. Olson, Peter Albers, Christian Vokuhl, Raimund Stein, Leendert Looijenga, Jalid Sehouli, Martin Metzelder, Alexander Claviez, Michael Dworzak, Angelika Eggert, Birgit Fröhlich, Nicolas U. Gerber, Christian P. Kratz, Jörg Faber, Thomas Klingebiel, Dieter Harms, Ulrich Göbel

    Published 2020-03-01
    Get full text
    Article
  13. 13
    No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Care Therapy

    No Improvement of Survival for Alveolar Rhabdomyosarcoma Patients After HLA-Matched Versus -Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Compared to Standard-of-Ca... by Sebastian Johannes Schober, Erika Hallmen, Florian Reßle, Hendrik Gassmann, Carolin Prexler, Angela Wawer, Irene von Luettichau, Ruth Ladenstein, Bernarda Kazanowska, Gustaf Ljungman, Felix Niggli, Olli Lohi, Julia Hauer, Bernd Gruhn, Thomas Klingebiel, Peter Bader, Stefan Burdach, Peter Lang, Monika Sparber-Sauer, Monika Sparber-Sauer, Ewa Koscielniak, Ewa Koscielniak, Uwe Thiel

    Published 2022-05-01
    Get full text
    Article
  14. 14
    Desmoplastic small round cell tumors: Multimodality treatment and new risk factors

    Desmoplastic small round cell tumors: Multimodality treatment and new risk factors by Monika Scheer, Christian Vokuhl, Bernd Blank, Erika Hallmen, Thekla von Kalle, Marc Münter, Rüdiger Wessalowski, Maite Hartwig, Monika Sparber‐Sauer, Paul‐Gerhardt Schlegel, Christof M. Kramm, Udo Kontny, Bernd Spriewald, Thomas Kegel, Sebastian Bauer, Bernarda Kazanowska, Felix Niggli, Ruth Ladenstein, Gustaf Ljungman, Kirsi Jahnukainen, Jörg Fuchs, Stefan S. Bielack, Thomas Klingebiel, Ewa Koscielniak, the Cooperative Weichteilsarkom Studiengruppe [CWS]

    Published 2019-02-01
    Get full text
    Article
  15. 15
    The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their ex vivo Expansion and Cytotoxic Potential Against Neuroblastoma: Perspective for Optimized Immunotherapy Post Haploidentical Stem Cell Transplantation

    The Synergistic Use of IL-15 and IL-21 for the Generation of NK Cells From CD3/CD19-Depleted Grafts Improves Their ex vivo Expansion and Cytotoxic Potential Against Neuroblastoma:... by Annekathrin Heinze, Annekathrin Heinze, Annekathrin Heinze, Beatrice Grebe, Beatrice Grebe, Melanie Bremm, Melanie Bremm, Sabine Huenecke, Sabine Huenecke, Tasleem Ah. Munir, Tasleem Ah. Munir, Lea Graafen, Lea Graafen, Jochen T. Frueh, Jochen T. Frueh, Michael Merker, Michael Merker, Eva Rettinger, Eva Rettinger, Jan Soerensen, Jan Soerensen, Thomas Klingebiel, Peter Bader, Peter Bader, Evelyn Ullrich, Evelyn Ullrich, Evelyn Ullrich, Evelyn Ullrich, Claudia Cappel, Claudia Cappel

    Published 2019-12-01
    Get full text
    Article
  16. 16
    A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against Rhabdomyosarcoma

    A Two-Phase Expansion Protocol Combining Interleukin (IL)-15 and IL-21 Improves Natural Killer Cell Proliferation and Cytotoxicity against Rhabdomyosarcoma by Juliane Wagner, Juliane Wagner, Juliane Wagner, Viktoria Pfannenstiel, Viktoria Pfannenstiel, Viktoria Pfannenstiel, Anja Waldmann, Judith W. J. Bergs, Judith W. J. Bergs, Judith W. J. Bergs, Boris Brill, Sabine Huenecke, Sabine Huenecke, Thomas Klingebiel, Franz Rödel, Franz Rödel, Franz Rödel, Christian J. Buchholz, Christian J. Buchholz, Christian J. Buchholz, Winfried S. Wels, Winfried S. Wels, Winfried S. Wels, Peter Bader, Peter Bader, Evelyn Ullrich, Evelyn Ullrich, Evelyn Ullrich

    Published 2017-06-01
    Get full text
    Article

Search Tools: